Evidence-Based Medicine
Copyright ©The Author(s) 2015.
World J Gastroenterol. Apr 28, 2015; 21(16): 5039-5048
Published online Apr 28, 2015. doi: 10.3748/wjg.v21.i16.5039
Table 5 Comparison of clinical data between subjects of cohort I and II with and without deletion variants n (%)
Clinical factorCohort I
Cohort II
Wild type (n = 192)Deletion (n = 72)P valueWild type (n = 49)Deletion (n = 28)P value
Age in years, mean ± SD46.3 ± 15.744.7 ± 17.80.47135.8 ± 8.939.1 ± 11.10.186
Male148 (77.1)52 (72.2)0.42320 (40.8)16 (57.1)0.235
HBeAg-positive98 (51.0)54 (75.0)< 0.00129 (69.2)26 (92.9)0.002
Liver disease (C : CH : LC : HCC)43 : 27 : 47 : 7520 : 6 : 12 : 3418 : 319 : 19
ALT [IU/liter (mean ± SD)]87.7 ± 182.454.4 ± 33.50.295125.5 ± 271.2120.9 ± 160.30.935
Median of HBV-DNA (range)797.7 (0-6000)11678.9 (0-6000)10.0138.3 × 108 (100-10.1 × 109)22.2 × 109 (2.3 × 103-15.1 × 109)20.049